AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.
|Articles|March 30, 2020
GOED issues industry advisory on omega-3 immunity claims
Author(s)Alissa Marrapodi
While omega-3 supplements play a key role in human health, GOED did not find sufficient data to link intake of EPA and DHA omega-3s to “general” to “viral” immunity benefits.
Advertisement
In response to the COVID-19 pandemic and confusion about the role omega-3s may play in immunity-based protection, the Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City) issued
Additionally,
Advertisement
Related to this article
Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
The proposed notification requirement is straightforward, but its legal and commercial consequences are not.
Advertisement
Advertisement